The American public has placed increasing pressure on manufacturers, regulators, and health systems to increase transparency of drug costs and alternatives. Understanding medication cost is an important first step, but patients – as well as providers – need transparency into spend on specific drugs as well as appropriate, lower-cost alternatives.
Download this report to:
- Gain transparency into recent trends in hospital drug spending for several indications that are historically expensive to treat
- Understand lower-cost alternative therapies, where clinically warranted, for these expensive indications, and elucidate whether prescribers are prescribing these alternatives
- See Lumere’s insights into the regulatory, economic and market factors that are playing a role in the observed hospital spending shifts